Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

nder)20112010

2010

2011

2010

2010Zyprexa®

$1,182.3$1,212.7(3)%$3,872.4$3,690.65%Cymbalta®

1,068.6825.329%2,980.82,496.219%Alimta

629.7560.312%1,823.01,639.511%Humalog®

593.2494.020%1,705.51,505.113%Cialis

469.8406.516%1,381.41,233.512%Humulin®

301.5278.08%903.2801.013%Evista®

270.1256.85%799.7757.96%Forteo®

240.3199.720%687.3603.814%Strattera

153.2127.920%449.5421.37%Gemzar

91.0324.6(72)%359.5905.8(60)%Animal Health

451.0353.228%1,210.4967.025%Total Revenue

$6,147.9$5,654.89%$18,239.9$16,889.08%Zyprexa

In the third quarter of 2011, Zyprexa sales totaled $1.182 billion, a decrease of 3 percent compared with the third quarter of 2010.  U.S. sales of Zyprexa decreased 7 percent to $563.2 million, driven by lower volume, partially offset by higher net effective selling prices. Zyprexa sales in international markets increased 2 percent, to $619.1 million, driven primarily by the favorable impact of foreign exchange rates, partially offset by lower prices and lower volume. The company lost patent exclusivity for Zyprexa in most of Europe in September 2011 and will lose exclusivity in the U.S. on October 23, 2011. While it is difficult to predict the precise timing and magnitude of the impact on Zyprexa sales, the company expects the introduction of generics to result in a rapid and severe decline in Zyprexa sales.  

Cymbalta

For the third quarter of 2011, Cymbalta generated $1.069 billion in revenue, an increase of 29 percent compared with the third quarter of 2010. U.S. sales of Cymbalta increased 26 percent, to $809.5 million, driven by increased prices and higher demand. Revenue outside the U.S. was $259.1 million, an increase of 42 percent, driven primarily by higher demand in international markets and, to a lesser extent, the favorable impact of foreign exchange rates.

Alimta

For the
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Declares Fourth-Quarter 2011 Dividend
2. Lilly Announces Changes in Senior Management
3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
7. Lilly Health Channel Debuts on YouTube
8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... NASHVILLE, Tenn. , April 30, 2015  Cumberland ... it will release first quarter 2015 financial results after ... conference call and live Internet webcast will be held ... Time to discuss the results. To participate ... or 253-237-1032 (for international callers).  A rebroadcast of the ...
(Date:4/30/2015)... 2015  Nektar Therapeutics (Nasdaq: NKTR ) today ... March 31, 2015. Cash and investments ... million as compared to $262.8 million at December 31, ... March 31, 2015 includes a $100.0 million milestone payment ... commercial sale of Movantik™(naloxegol) in the U.S. ...
(Date:4/30/2015)... plc (NYSE: PRGO ; TASE) today announced that Perrigo Chairman, ... the 2015 Deutsche Bank 40 th Annual Healthcare Conference at ... in Boston , MA.  The ... C. Papa will present at the Bank of America Merrill ... 2015 at the Encore at Wynn Las Vegas Hotel in ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 3Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 4Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 5Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 6Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 7Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 8Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 9Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 10Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 11Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 12Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
... Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that ... New Drugs ("OND") in Maryland and presented its arguments supporting ... Drug Application ("NDA") 22-481 support the conclusion that pixantrone is ... consideration of our appeal.  While we understand disputes of this ...
... SQNM ), today announced the awards of non-qualified ... common stock for six new employees under the company,s New ... Of these shares, 14,450 have an exercise price ... Sequenom,s common stock on February 28, and 60,000 have a ...
Cached Medicine Technology:FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 2FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 3Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3
(Date:5/1/2015)... 2015 The fields of genetics and ... interplay of genes with one another and the environment, ... daunting. , LabRoots, the premier producer of interactive virtual ... soon host its annual conference spotlighting the recent advances ... Genetics and Genomics 2015 , a two-day event presented ...
(Date:5/1/2015)... Today the United Nations Foundation’s Girl Up campaign announced that ... the rights of adolescent girls in India. This announcement ... Up began almost five years ago – kicks off a ... the Rajasthan region of India. , “For the past ... girls in Guatemala, Ethiopia, Liberia, and Malawi. As we ...
(Date:5/1/2015)... 01, 2015 Digital technology and Wi-Fi-enabled ... women between prenatal appointments, a preliminary study ... small sample of low-risk pregnant women, will be presented ... University Medical Faculty Associates at the 2015 American Congress ... Meeting, May 2-6. The digital technology used was developed ...
(Date:5/1/2015)... On May 5 the frozen yogurt chain ... Mayo with a twist. The new Cinco de Froyo ... one 24 ounce frozen yogurt for $5.55 at participating stores. ... 1862 in commemoration of a Mexican victory over the French. ... States, but events are also held in such distant locales ...
(Date:5/1/2015)... in five Americans suffer from at least one type ... With warmer weather hitting a majority of the country, ... sixth edition of "Allergies and Asthma," a guide for ... triggers, manage symptoms and enjoy springtime. , "Thanks ... , everyone has friends or family members who are ...
Breaking Medicine News(10 mins):Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3Health News:sweetFrog to Celebrate Cinco de Mayo with a Yogurt Twist 2Health News:Living a Life Without Limits Through Mediaplanet’s Allergies and Asthma Campaign 2
... also repair damaged ankles claim the researchers. ,Arthroscopy ... but it is also a valuable method for treating ... technique it is being applied in new ways by ... damage, bone chips and recurrent pain from end-stage arthritis. ...
... disease, is becoming an elite disease as so much of ... As a result of such ongoing research, hyperhomocysteinemia (increased levels ... the risk factors.// ,Dr. O Mayer Jr and colleagues ... result of their study that beer may provide enough folate--a ...
... strike a pot of gold by making cheap anti-AIDS ... likely to escalate in coming days. ,The large ... develop anti-AIDS drugs and market it in India and ... anti-AIDS drug market, currently dominated by Mumbai-based Cipla, witnessed ...
... health"- this warning , printed in every cigarette carton ,had been ... many. But now the fact that even a single cigarette is ... of North Carolina. ,It is a well known fact that ... as heart attack , cancer etc.,. Dr. Firas A. ...
... improve mood and reduce fatigue, study reports. ,It is a ... asset. But as far as mental fatigue is concerned, there was ... based on the preliminary findings which included 14 women who did ... benefits as far as mood is concerned. ,Cheryl J. Hansen ...
... Crohn's disease and ulcerative colitis, often grouped together ... of modern, industrialized nations with stringent standards of ... prevents the human immune system from interacting with ... to develop properly...Yes! Doctors at the University of ...
Cached Medicine News:Health News:Arthroscopy for Ankles 2Health News:WORM! WORM! all the way 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: